TY - JOUR
T1 - Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention
T2 - An International Consensus Paper
AU - RAO International Group
AU - Bernat, Ivo
AU - Aminian, Adel
AU - Pancholy, Samir
AU - Mamas, Mamas
AU - Gaudino, Mario
AU - Nolan, James
AU - Gilchrist, Ian C.
AU - Saito, Shigeru
AU - Hahalis, George N.
AU - Ziakas, Antonio
AU - Louvard, Yves
AU - Montalescot, Gilles
AU - Sgueglia, Gregory A.
AU - van Leeuwen, Maarten A.H.
AU - Babunashvili, Avtandil M.
AU - Valgimigli, Marco
AU - Rao, Sunil V.
AU - Bertrand, Olivier F.
N1 - Funding Information:
Dr. Bertrand has served as the International Chair on Interventional Cardiology and Transradial Approach, Laval University, Quebec City, Canada. Dr. Aminian has received consulting/lecture fees from Terumo. Dr. Pancholy owns equity in Vasoinnovations, Inc.; and has served as a speaker for Medtronic and Terumo. Dr. Gilchrist has served as a consultant for Terumo and Cardinal Health. Dr. Montalescot has received institutional research grants or consulting/lecture fees from Abbott, Amgen, Actelion, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Beth Israel Deaconess Medical, Brigham Women's Hospital, Cardiovascular Research Foundation, Daiichi-Sankyo, Idorsia, Europa, Elsevier, F?d?ration Fran?aise de Cardiologie, ICAN, Medtronic, Journal of the American College of Cardiology, Lead-Up, Menarini, MSD, Novo-Nordisk, Pfizer, Sanofi, Servier, The Mount Sinai School, TIMI Study Group, and WebMD. Dr. Valgimigli has received grants and personal fees from Abbott; has received personal fees from Chiesi, Bayer, Daiichi-Sankyo, Amgen, Alvimedica, Biosensors, and Idorsia outside the submitted work; has received grants and personal fees from Terumo and AstraZeneca; and has received grants from Medicure. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2019
PY - 2019/11/25
Y1 - 2019/11/25
N2 - Transradial access (TRA) is increasingly used worldwide for percutaneous interventional procedures and associated with lower bleeding and vascular complications than transfemoral artery access. Radial artery occlusion (RAO) is the most frequent post-procedural complication of TRA, restricting the use of the same radial artery for future procedures and as a conduit for coronary artery bypass graft. The authors review recent advances in the prevention of RAO following percutaneous TRA diagnostic or interventional procedures. Based on the available data, the authors provide easily applicable and effective recommendations to prevent periprocedural RAO and maximize the chances of access in case of repeat catheterization or coronary artery bypass grafting surgery.
AB - Transradial access (TRA) is increasingly used worldwide for percutaneous interventional procedures and associated with lower bleeding and vascular complications than transfemoral artery access. Radial artery occlusion (RAO) is the most frequent post-procedural complication of TRA, restricting the use of the same radial artery for future procedures and as a conduit for coronary artery bypass graft. The authors review recent advances in the prevention of RAO following percutaneous TRA diagnostic or interventional procedures. Based on the available data, the authors provide easily applicable and effective recommendations to prevent periprocedural RAO and maximize the chances of access in case of repeat catheterization or coronary artery bypass grafting surgery.
UR - http://www.scopus.com/inward/record.url?scp=85075000313&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075000313&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2019.07.043
DO - 10.1016/j.jcin.2019.07.043
M3 - Review article
C2 - 31753298
AN - SCOPUS:85075000313
VL - 12
SP - 2235
EP - 2246
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
SN - 1936-8798
IS - 22
ER -